Nabhasa Bio-Chem Private Limited
Chemical trading, import/export, distribution, retail, pharmaceuticals, nutraceuticals, healthcare, ayurvedic products.
2017 | Bangaluru, Karnataka (India) | Active
Nabhasa Bio-Chem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 50.86%
- Profit Growth 82.36%
- Ebitda 97.20%
- Net Worth -13.73%
- Total Assets -49.92%
About Nabhasa Bio-Chem
Nabhasa Bio-Chem Private Limited (NBPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 July 2017 (Seven years and seven months 5 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Monoharlal Rathanlal, Sanjay Jain, and Siddharth Jain serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999KA2017PTC104943
- Company No.
104943
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Chemicals and Materials
Pharma
Who are the key members and board of directors at Nabhasa Bio-Chem?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Monoharlal Rathanlal  | Director | 24-Jul-2017 | Current |
| Sanjay Jain | Director | 24-Jul-2017 | Current |
| Siddharth Jain | Director | 24-Jul-2017 | Current |
Financial Performance of Nabhasa Bio-Chem.
Nabhasa Bio-Chem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.86% increase. The company also saw a substantial improvement in profitability, with a 82.36% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nabhasa Bio-Chem?
In 2022, Nabhasa Bio-Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nabhasa Bio-Chem?
Unlock and access historical data on people associated with Nabhasa Bio-Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nabhasa Bio-Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nabhasa Bio-Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.